AcrySof IQ ReSTOR Posterior Chamber Intraocular Lenses
Alcon Research, Ltd. · Decision date Dec 12, 2025
What did the FDA decide?
FDA records P040020/S117 as a supplement to PMA P040020, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 12, 2025.
FDA approval order statement
approval of a new cleanroom (Controlled Environment (CE)) for Intraocular lenses manufactured at Alcon Huntington, West Virginia
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Dec 12, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P040020/S117
- Regulatory pathway
- PMA supplement
- Applicant
- Alcon Research, Ltd.
- Product code
- MFK
- Decision code
- OK30
- Decision date
- Dec 12, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lens, multifocal intraocular.
- Applicant
- Alcon Research, Ltd.
- Product code
- MFK
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P040020/S115 · Related supplement
AcrySof IQ ReSTOR Posterior Chamber Intraocular Lenses\s
P040020/S116 · Related supplement
AcrySof IQ ReSTOR Posterior Chamber Intraocular Lenses
P040020/S117 received
Application receipt date recorded by FDA.
P040020/S117 · FDA decision
30-Day Notice
P040020/S118 · Related supplement
AcrySof IQ ReSTOR Posterior Chamber Intraocular Lenses
P040020/S119 · Related supplement
AcrySof ReSTOR Apodized Diffractive Optic Posterior Chamber IOL
P040020/S121 · Related supplement
AcrySof IQ ReSTOR Posterior Chamber Intraocular Lenses
P040020/S120 · Related supplement
AcrySof ReSTOR Apodized Diffractive Optic Posterior Chamber IOL
Timeline entries are records held by MedtechLedger for P040020. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P040020
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Alcon Research, Ltd. | PMA supplement | Aug 25, 2025 | FDA | |
| Alcon Research, Ltd. | PMA supplement | Sep 18, 2025 | FDA | |
| Alcon Research, Ltd. | PMA supplement | Mar 2, 2026 | FDA | |
| Alcon Research, Ltd. | PMA supplement | Jul 2, 2026 | FDA | |
| Alcon Research, Ltd. | PMA supplement | Jul 2, 2026 | FDA | |
| Alcon Research, Ltd. | PMA supplement | Jul 6, 2026 | FDA |
Explore the linked device profile
Other records with product code MFK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ClearView HD intraocular lens (IOL)P200020/S013 | Lenstec, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
TECNIS Multi-focal 3-pc, Model ZMA00P080010/S032 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
| Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Sep 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Alcon Research, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 6201 S. Fwy., Fort Worth, TX, 76134
Sources and methodology
- Original FDA record: P040020/S117
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






